AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP



Bookmark and Share Print This Page
The people of AstraZeneca are dedicated to: Discovering, developing, and delivering innovative, meaningful medicines and other healthcare solutions that help enrich the lives of patients, as well as their families and communities. Putting the health of patients first by providing educational programs, resources, and tools designed to help empower and inform. Creating a challenging and rewarding work environment that inspires our employees.


Member in Photos


Member in the News


Jan

21

Investing in health of Delaware teens

Astra-Zeneca and United Way of Delaware on Friday launched a cooperative initiative

Read More >

Mar

13

Delaware Jobs: Good teachers, good graduates, good jobs

Delaware creates workforce that is college and career ready

Read More >

Apr

28

AstraZeneca Posts $2.91B First-Quarter Profit

AstraZeneca reported profits of $2.91 billion for the three months ending in March, up from $2.78 billion last year

Read More >

Mar

15

AstraZeneca Recognized as a Top Company for Female Executives

AstraZeneca named one of the top 50 companies for female executives for the third consecutive year

Read More >

Apr

25

Pharmaceuticals – Retraction and Opportunity

Latest news in the Pharmaceutical Industry

Read More >

Apr

27

Technology provides greater accessibility and convenience to patients, caregivers

AstraZeneca (NYSE:AZN) announced today the launch of “click-to-chat” on CRESTOR.com and PurplePill.com.

Read More >

Apr

23

AstraZeneca Fuels Biotech M&A with $1.3 billion Ardea Buy

AstraZeneca is to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster a weak pipeline in a deal that feeds a wave of M&A in the biotechnology sector.

Read More >